CStone Reports CS2009 Data From More Than 300 Patients at ESMO
CStone said data from more than 300 patients supported CS2009’s mechanism, safety and antitumor activity across multiple solid tumors.
CStone said data from more than 300 patients supported CS2009’s mechanism, safety and antitumor activity across multiple solid tumors.